학술논문
1895P Time to treatment failure (TTF) and treatment beyond progression (TBP) in pretreated metastatic renal cell carcinoma (mRCC) patients (pts) receiving nivolumab: A survival outcome and a therapeutic strategy of clinical benefit (meet-uro 15)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1020-S1020
Subject
Language
ISSN
0923-7534